JSM 2025 — MuCopilot®: optimizing cystic fibrosis monitoring through digital biomarkers

At the Cystic Fibrosis Scientific Days 2025 (JSM), we presented the development of MuCopilot®, our Software as a Medical Device (SaMD) dedicated to home cystic fibrosis monitoring.

The study demonstrates the technical feasibility of measuring three key biomarkers using only smartphone sensors: respiratory function (phonation time), nocturnal cough, and endurance.

Through three usability studies involving 23 patients, a co-design approach led to 36 concrete improvements, ensuring a solution adapted to real-world conditions.